Cite
Flume PA, Aitken ML, Bilton D, et al. Optimising inhaled mannitol for cystic fibrosis in an adult population. Breathe (Sheff). 2015;11(1):39-48doi: 10.1183/20734735.021414.
Flume, P. A., Aitken, M. L., Bilton, D., Agent, P., Charlton, B., Forster, E., Fox, H. G., Hebestreit, H., Kolbe, J., Zuckerman, J. B., & Button, B. M. (2015). Optimising inhaled mannitol for cystic fibrosis in an adult population. Breathe (Sheffield, England), 11(1), 39-48. https://doi.org/10.1183/20734735.021414
Flume, Patrick A, et al. "Optimising inhaled mannitol for cystic fibrosis in an adult population." Breathe (Sheffield, England) vol. 11,1 (2015): 39-48. doi: https://doi.org/10.1183/20734735.021414
Flume PA, Aitken ML, Bilton D, Agent P, Charlton B, Forster E, Fox HG, Hebestreit H, Kolbe J, Zuckerman JB, Button BM. Optimising inhaled mannitol for cystic fibrosis in an adult population. Breathe (Sheff). 2015 Mar;11(1):39-48. doi: 10.1183/20734735.021414. PMID: 26306102; PMCID: PMC4487380.
Copy
Download .nbib